Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 218

Similar articles for PubMed (Select 14684442)

1.

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment.

Laruelle M, Kegeles LS, Abi-Dargham A.

Ann N Y Acad Sci. 2003 Nov;1003:138-58. Review.

PMID:
14684442
2.

Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.

Laruelle M, Frankle WG, Narendran R, Kegeles LS, Abi-Dargham A.

Clin Ther. 2005;27 Suppl A:S16-24. Review.

PMID:
16198197
3.

Schizophrenia: from dopaminergic to glutamatergic interventions.

Laruelle M.

Curr Opin Pharmacol. 2014 Feb;14:97-102. doi: 10.1016/j.coph.2014.01.001. Epub 2014 Feb 11. Review.

PMID:
24524997
4.
5.
6.
7.

[Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].

Mechri A, Saoud M, Khiari G, d'Amato T, Dalery J, Gaha L.

Encephale. 2001 Jan-Feb;27(1):53-9. Review. French.

PMID:
11294039
8.

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

Kegeles LS, Abi-Dargham A, Zea-Ponce Y, Rodenhiser-Hill J, Mann JJ, Van Heertum RL, Cooper TB, Carlsson A, Laruelle M.

Biol Psychiatry. 2000 Oct 1;48(7):627-40.

PMID:
11032974
9.

The role of extrastriatal dopamine D2 receptors in schizophrenia.

Takahashi H, Higuchi M, Suhara T.

Biol Psychiatry. 2006 May 15;59(10):919-28. Review.

PMID:
16682269
10.

Glutamate and schizophrenia: beyond the dopamine hypothesis.

Coyle JT.

Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):365-84. Epub 2006 Jun 14. Review.

PMID:
16773445
12.

Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopamine and glutamate in the prefrontal cortex.

Del Arco A, Mora F.

Pharmacol Biochem Behav. 2008 Aug;90(2):226-35. doi: 10.1016/j.pbb.2008.04.011. Epub 2008 Apr 23. Review.

PMID:
18508116
13.

The neuropathology of schizophrenia.

Bachus SE, Kleinman JE.

J Clin Psychiatry. 1996;57 Suppl 11:72-83. Review.

PMID:
8941174
14.

Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review.

Stone JM, Morrison PD, Pilowsky LS.

J Psychopharmacol. 2007 Jun;21(4):440-52. Epub 2007 Jan 26. Review.

PMID:
17259207
15.

Calcium modulates dopamine potentiation of N-methyl-D-aspartate responses: electrophysiological and imaging evidence.

Liu JC, DeFazio RA, Espinosa-Jeffrey A, Cepeda C, de Vellis J, Levine MS.

J Neurosci Res. 2004 May 1;76(3):315-22.

PMID:
15079860
17.

Glutamatergic animal models of schizophrenia.

Moghaddam B, Jackson ME.

Ann N Y Acad Sci. 2003 Nov;1003:131-7. Review.

PMID:
14684441
18.

Comorbidity of substance abuse with other psychiatric disorders.

Palomo T, Archer T, Kostrzewa RM, Beninger RJ.

Neurotox Res. 2007 Jul;12(1):17-27. Review.

PMID:
17513197
20.

GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum.

Balla A, Nattini ME, Sershen H, Lajtha A, Dunlop DS, Javitt DC.

Neuropharmacology. 2009 Apr;56(5):915-21. doi: 10.1016/j.neuropharm.2009.01.021. Epub 2009 Feb 6.

PMID:
19371582
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk